Evidence map›Paper›PMID 25211324›Full record

ArticleDNA and cell biology2014

The transcriptional activator Ino2p dissociates from the yeast INM1 promoter in induction.

Lingzhi Zhang, Jing Di

Open access · greenAbstract read
In one paragraph

Article in DNA and cell biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Lingzhi Zhang1 Department of Emergency, Shengjing Hospital of China Medical University , Shenyang, China .
Jing Di
China Medical University · CNCollege of Staten Island · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mood stabilizers lithium and valproates are widely used in the treatment of bipolar disorder. It has been shown that these drugs can affect the inositol monophosphatase activity and thus the inositol de novo biosynthesis. However, the molecular mechanism of this action has thus far been vague. As such, characterizing the regulation of the gene encoding inositol monophosphatase at the molecular level can help to understand the bipolar disorder. As the model organism, the inositol monophosphatase is encoded by INM1 in Saccharomyces cerevisiae. In this study, we showed, using real-time reverse transcriptase polymerase chain reaction analysis, that INM1 is expressed in the presence of inositol, suggesting that the presence of inositol is required for INM1 transcriptional activation. We also demonstrated, using chromatin immunoprecipitation, that Ino2p is present at the promoter under uninduced conditions. Upon induction, Ino2p dissociates from the INM1 promoter. Furthermore, chromatin remodelers Ino80p and Snf2p are recruited to INM1 promoter upon induction as well as histone acetylases Gcn5p and Esa1p. Altogether, we have provided the evidence which describes how the transcriptional activator and coactivators participate in INM1 activation.

Indexed as

Transcriptional ActivationBasic Helix-Loop-Helix ProteinsEnzyme InductionGene Expression Regulation, FungalHistone AcetyltransferasesInositolp300-CBP-Associated FactorPhosphoric Monoester HydrolasesPromoter Regions, GeneticProtein BindingSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsBasic Helix-Loop-Helix ProteinsEsa1 protein, S cerevisiaeGCN5 protein, S cerevisiaeHistone AcetyltransferasesINO2 protein, S cerevisiaeInositolmyo-inositol-1 (or 4)-monophosphatasep300-CBP-Associated FactorPhosphoric Monoester HydrolasesSaccharomyces cerevisiae Proteins

Identifiers

PMID25211324
PMCPMC4248251
OpenAlexW2327544975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.